• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂蛋白(a)的蛋白质组学鉴定出与创伤反应相关的蛋白质补体。

Proteomics of Lipoprotein(a) identifies a protein complement associated with response to wounding.

机构信息

Department of Biochemistry, University of Otago, Dunedin, New Zealand.

出版信息

J Proteomics. 2011 Nov 18;74(12):2881-91. doi: 10.1016/j.jprot.2011.07.008. Epub 2011 Jul 23.

DOI:10.1016/j.jprot.2011.07.008
PMID:21802535
Abstract

Lipoprotein(a) [Lp(a)] is a major independent risk factor for cardiovascular disease. Twenty percent of the general population exhibit levels above the risk threshold highlighting the importance for clinical and basic research. Comprehensive proteomics of human Lp(a) will provide significant insights into Lp(a) physiology and pathogenicity. Using liquid chromatography-coupled mass spectrometry, we established a high confidence Lp(a) proteome of 35 proteins from highly purified particles. Protein interaction network analysis and functional clustering revealed proteins assigned to the two major biological processes of lipid metabolism and response to wounding. The latter includes the processes of coagulation, complement activation and inflammatory response. Furthermore, absolute protein quantification of apoB-100, apo(a), apoA1, complement C3 and PON1 gave insights into the compositional stoichiometry of associated proteins per particle. Our proteomics study has identified Lp(a)-associated proteins that support a suggested role of Lp(a) in response to wounding which points to mechanisms of Lp(a) pathogenicity at sites of vascular injury and atherosclerotic lesions. This study has identified a high confidence Lp(a) proteome and provides an important basis for further comparative and quantitative analyses of Lp(a) isolated from greater numbers of plasma samples to investigate the significance of associated proteins and their dynamics for Lp(a) pathogenicity.

摘要

脂蛋白(a) [Lp(a)] 是心血管疾病的主要独立危险因素。20%的普通人群的 Lp(a) 水平超过了风险阈值,这突显了临床和基础研究的重要性。对人类 Lp(a) 的综合蛋白质组学研究将为 Lp(a) 的生理学和发病机制提供重要的见解。我们使用液相色谱-串联质谱法,从高度纯化的颗粒中确定了 35 种具有高可信度的 Lp(a) 蛋白质组。蛋白质相互作用网络分析和功能聚类揭示了分配给脂质代谢和对创伤反应这两个主要生物学过程的蛋白质。后者包括凝血、补体激活和炎症反应过程。此外,apoB-100、apo(a)、apoA1、补体 C3 和 PON1 的绝对蛋白定量深入了解了每个颗粒中相关蛋白的组成比例。我们的蛋白质组学研究鉴定了与 Lp(a) 相关的蛋白质,这些蛋白质支持了 Lp(a) 在对创伤反应中的作用,这表明了 Lp(a) 在血管损伤和动脉粥样硬化病变部位的发病机制。本研究确定了高可信度的 Lp(a) 蛋白质组,为进一步对来自更多血浆样本的 Lp(a) 进行比较和定量分析提供了重要基础,以研究相关蛋白及其动力学对 Lp(a) 发病机制的意义。

相似文献

1
Proteomics of Lipoprotein(a) identifies a protein complement associated with response to wounding.脂蛋白(a)的蛋白质组学鉴定出与创伤反应相关的蛋白质补体。
J Proteomics. 2011 Nov 18;74(12):2881-91. doi: 10.1016/j.jprot.2011.07.008. Epub 2011 Jul 23.
2
Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.烟酸缓释剂对 2 型糖尿病合并他汀类药物治疗的男性患者餐后脂蛋白 (a) 和载脂蛋白 B-100 脂蛋白代谢的影响。
Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2686-93. doi: 10.1161/ATVBAHA.115.306136. Epub 2015 Oct 29.
3
Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.针对人载脂蛋白B-100的反义寡核苷酸可降低载脂蛋白(a)转基因小鼠中载脂蛋白(a)颗粒上的载脂蛋白(a)水平和氧化磷脂。
Circulation. 2008 Aug 12;118(7):743-53. doi: 10.1161/CIRCULATIONAHA.108.786822. Epub 2008 Jul 28.
4
The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.人类血浆脂蛋白(a)中载脂蛋白(a)和B-100的代谢
Metabolism. 2005 Mar;54(3):361-9. doi: 10.1016/j.metabol.2004.10.001.
5
Analytical Performance Specifications for Lipoprotein(a), Apolipoprotein B-100, and Apolipoprotein A-I Using the Biological Variation Model in the EuBIVAS Population.脂蛋白(a)、载脂蛋白 B-100 和载脂蛋白 A-I 的分析性能规格,采用 EuBIVAS 人群中的生物学变异模型。
Clin Chem. 2020 May 1;66(5):727-736. doi: 10.1093/clinchem/hvaa054.
6
In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a).体内稳定同位素动力学研究提示脂蛋白(a)的细胞内组装。
Atherosclerosis. 2012 Dec;225(2):322-7. doi: 10.1016/j.atherosclerosis.2012.09.031. Epub 2012 Oct 5.
7
Hyperhomocysteinemia and hyperlipoproteinemia (a) in obese South Indian men: an indication for increased cardiovascular risk.肥胖的南印度男性中的高同型半胱氨酸血症和高脂蛋白血症(a):心血管风险增加的一个指征
Acta Physiol Hung. 2014 Mar;101(1):13-20. doi: 10.1556/APhysiol.100.2013.017.
8
Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular risk.脂蛋白(a)与血小板:心血管风险潜在机制
Pathophysiol Haemost Thromb. 2006;35(3-4):314-21. doi: 10.1159/000093224.
9
Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.氧化磷脂、脂蛋白(a)与冠状动脉疾病
N Engl J Med. 2005 Jul 7;353(1):46-57. doi: 10.1056/NEJMoa043175.
10
[Lipoprotein(a): characteristics of a special lipoprotein and its potential clinical significance].[脂蛋白(a):一种特殊脂蛋白的特性及其潜在临床意义]
Ther Umsch. 1990 Jun;47(6):475-81.

引用本文的文献

1
Lipoprotein(a) and Effects of Diet: Time for Reassessment.脂蛋白(a)与饮食的影响:重新评估的时候了。
Nutrients. 2025 May 19;17(10):1714. doi: 10.3390/nu17101714.
2
Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics.通过蛋白质组学解读急性冠脉综合征的病理生物学
J Cardiovasc Dev Dis. 2025 May 15;12(5):188. doi: 10.3390/jcdd12050188.
3
2024: The year in cardiovascular disease - the year of lipoprotein(a). Research advances and new findings.2024年:心血管疾病之年——脂蛋白(a)之年。研究进展与新发现。
Arch Med Sci. 2025 Feb 22;21(2):355-373. doi: 10.5114/aoms/202213. eCollection 2025.
4
Lipoprotein(a) as a Stroke Biomarker: Pathophysiological Pathways and Therapeutic Implications.脂蛋白(a)作为一种中风生物标志物:病理生理途径及治疗意义
J Clin Med. 2025 Apr 25;14(9):2990. doi: 10.3390/jcm14092990.
5
Lipoprotein(a) and thromboembolism: current state of knowledge and unsolved issues.脂蛋白(a)与血栓栓塞:当前的知识现状及未解决的问题。
Arch Med Sci. 2024 Dec 13;20(6):1770-1783. doi: 10.5114/aoms/197357. eCollection 2024.
6
High lipoprotein(a): Actionable strategies for risk assessment and mitigation.高脂蛋白(a):风险评估与缓解的可行策略
Am J Prev Cardiol. 2024 Apr 3;18:100651. doi: 10.1016/j.ajpc.2024.100651. eCollection 2024 Jun.
7
Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?靶向脂蛋白(a):RNA疗法能否成为预防心血管疾病的下一步方案?
Cardiol Ther. 2024 Mar;13(1):39-67. doi: 10.1007/s40119-024-00353-w. Epub 2024 Feb 21.
8
Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting.血栓形成还是不形成?脂质与凝血的相互调节综述。
Arterioscler Thromb Vasc Biol. 2024 Mar;44(3):533-544. doi: 10.1161/ATVBAHA.123.318286. Epub 2024 Jan 18.
9
Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability.通过蛋白质组学寻找动脉粥样硬化生物标志物:关注病变发病机制和易损性。
Int J Mol Sci. 2023 Oct 14;24(20):15175. doi: 10.3390/ijms242015175.
10
Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?脂蛋白(a):仅仅是高血压的无辜旁观者吗?
Int J Mol Sci. 2023 Aug 29;24(17):13363. doi: 10.3390/ijms241713363.